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Aim. Colonic polyps and thyroid nodules are common diseases and their frequency increases with age. In the literature, there is
no study investigating the coexistence of colonic polyps and thyroid nodules. Therefore, this study was designed to investigate
thyroid nodule prevalence in patients with colonic polyps. Material and Methods. Sixty-six patients with colonic polyps and 146
patients without colonic polyps enrolled into the study. Age and sex matched control group was composed from patients without
colonic polyps. Colonoscopic examinations, thyroid ultrasonographies were performed in all patients, and TSH were measured.
Results. Male/female ratio in polyp and control groups were 40/26 versus 68/78, respectively (P = 0.058). Mean ages were similar
in both groups (53.3 ± 11.4v e r s u s ,5 1 .8 ± 11.4, P = 0.373). Thyroid nodule was detected in 44 (66.7%) patients with polyps and
in 61 (41.8%) controls (P = 0.001). Patients with adenomatous polyps had 5 or more thyroid nodules compared to patients with
hyperplastic polyps (P = 0.03). Thyroid nodules were more prevalent among patients aged 50 or older compared to 50 years or
less (P = 0.023). Conclusion. Thyroid nodules were detected more common in patients with colonic polyps. Further studies are
needed to clarify this coexistence.
1.Introduction
Colonic polyps and thyroid nodules are very common dis-
easesinthegeneralpopulationandtheirprevalenceincreases
with age [1, 2]. Epidemiological, clinicopathological, and
molecular genetic studies suggest that colorectal adenomas
(about two-thirds of all colonic polyps) are now considred
precursors of colonic adenocarcinomas. It has been shown
thatthescreeningandresectionoftheadenomasinasympto-
matic population provides a powerful tool to reduce colorec-
tal cancer incidence. Although the etiology of colorectal ade-
n o m a si sn o tw e l lu n d e r s t o o d ,t h e r ea r el a r g en u m b e r so f
clinicalenvironmentalandlifestylefactorsthatareassociated
with increased risk of colorectal adenomas [3].
Like colonic adenomas, thyroid nodule prevalence in-
creases with age in certain populations like females or in io-
dine deﬁcient regions. Ultrasound (US) and autopsy studies
report that thyroid nodule prevalence ranges from 19% to
50% [4, 5]. Based on our clinical observations, thyroid nod-
ules are more commonly seen in patients with colonic pol
yps. In the literature, there is no study investigating the coex
istence between colonic polyps and thyroid nodules. There-
fore,thisstudywasdesignedtoinvestigatethyroidnodulepre
valence in patients with colonic polyps.2 Gastroenterology Research and Practice
2.MaterialandMethods
This study is conducted in Divisions of Endocrinology and
Gastroenterology of Konya Training and Research Hospital
andBaskentUniversityMedicalFacultyKonyaTrainingHos-
pital, between 2008-2009. All colonic investigations were
evaluated, and patients with neoplastic colonic polyps were
enrolled in the study. Patients with all types of malignancies,
ulcerative colitis, submucosal, mucosal, inﬂammatory pseu-
dopolyp, known familial polyposis coli syndrome, usage of
l-thyroxine or antithyroid drug were excluded. After enroll-
ment, thyroid US was performed and all nodules detected
by US were recorded on patients form. Thyroid stimulat-
inghormone(TSH)andfreethyroxinelevelsweremeasured.
Sixty-six patients with colonic polyps and age and sex-
matched 146 patients without colonic polyps, as a control
group, included in the study. Procedures were applied in
agreement with ethical committee.
ColonoscopicexaminationswereperformedbyOlympus
CF-Q180 AL video colonoscope, and the number and local-
ization of the polyps were recorded. When polyp was detect-
ed, and biopsy and resection was performed, pathological
characteristics were recorded. Thyroid US scanning was per-
formedusingthe5–13MHzlinearprobe,bySiemensAcuson
Antares.WeconsideredasthyroidnodulesalltheUSnodular
lesions ≥3mm. The number of thyroid nodules were divided
according to the largest diameter as <10mm and ≥10mm
and recorded.
AllstatisticalanalyseswereperformedwithSPSSver.17.0.
Shapiro Wilk test was used as normality test. Continuous
variables were compared with Student t-test for normally
distributed data and Mann-Whitney U test for nonnormal
distributed data. Categorical variables were compared using
Pearson’s chi-squared test and Fisher’s exact test. A P value <
0.05 was considered as signiﬁcant.
3. Results
In this period, 965 colonoscopies were performed and 191
patients with colonic polyps were detected. After the exclu-
sion, patients were asked to participate, among them 66 with
colonic polyp, and a total of 212 patients were included into
the study. Male/female ratio in polyp and control groups
were 40/26 versus 68/78, respectively (P = 0.058). Mean ages
were similar in both groups (53.3 ± 11.4v e r s u s ,5 1 .8 ± 11.4,
P = 0,373). Thyroid nodule prevalence was higher in pa-
tients with colonic polyps (44/66, 66.7%) than controls
(61/146, 41.8%), (P = 0.001), (Figure 1). Forty-six patients
h a ds i n g l ep o l y p ,9h a d2p o l y p s ,7h a d3a n d4h a d4o r
more polyps. Most of them were localized in rectosigmoidal
region.
Histopathological examination revealed adenomatous
polyp in 36 (55%) patients, hyperplastic polyp in 20 (30%)
patients, and mixed type in 10 (10%). None of the polyps
were malignant. In the polyp group, 46 patients had single
polyp and 31 of them had thyroid nodules, 20 patients had
2 or more polyps and amongv these, 13 patients had thyroid
nodules (P = 0.85).
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Figure 1: Percentage of patients with or without thyroid nodules.
In patients with colonic polyp, 36 patients had 4 or
less thyroid nodules and 8 patients had 5 or more thyroid
nodules. Patients with adenomatous polyps had 5 or more
thyroid nodules compared to patients with hyperplastic
polyps (in the hyperplastic polyp group, there was not any
patients with 5 or more thyroid nodules) (P = 0.033).
When patients with thyroid nodules were classiﬁed, 95
patientshad4andlessthan4thyroidnodulesand10patients
had 5 or more thyroid nodules.
Mean TSH levels were lower in the polyp group than
controls (1.17 ± 0.95 versus 1.54 ± 1.3, P = 0.002, resp.).
Thyroid nodules were greater than 10mm in 34 (32%)
patients. Age has no implication on colonic polyp frequency;
thyroid nodules were more prevalent among patients aged 50
oroldercomparedto50yearsorless(underage50; 34/85, 50
or older; 71/127) (P = 0.023).
Colonic polyp, or thyroid nodule existence were similar
between sexes (P = 0.63 and P = 0.182, resp.).
4. Discussion
This is the ﬁrst study investigating that concomitance be-
tween colonic polyp and thyroid nodules, and we found a
higher thyroid nodule prevalence in patients with colonic
polyps. Also we found lower TSH levels in patients with co-
lonic polyps; patients with adenomatous polyps had 5 or
morethyroidnodulescomparedtopatientswithhyperplastic
polyps and thyroid nodules were more prevalent among pa-
tients aged 50 years or older.
Colonic polyp and thyroid nodules are common dis-
orders and their prevalence increases with age. Ultrasound
studies and autopsy studies report a prevalence of thyroid
nodules up to 50% in elderly patients and in women [4, 5].
Thyroid nodule prevalence is higher in iodine-deﬁcient area.
In our country, iodine propyhylaxis was started in 1999
and our region is the mildly iodine-deﬁcient area at the
moment (average urinary iodine concentration 92µg/L) [6].Gastroenterology Research and Practice 3
Similarly, colonic polyp prevalence increases up to 50% with
age 70 [2]. Although both disorders have diﬀerent etiopatho-
genic mechanism, coexistence of colonic polyp and thyroid
nodules mechanism is unknown, yet.
Recently, there are some studies pointing out that insulin
resistance may be the common mechanisms. Kurimoto et al.
reported that colonic polyp prevalence is higher in patient
with acromegaly or insulin resistance [7]. In both situations
high insulin or insulin-like growth hormone-1 levels may
cause increased polyp formation. In patients with metabolic
syndrome, colonic polyp prevalence is increased and insulin
resistance is responsible for this situation [8, 9].
Similarly, some studies reported a coexistence between
insulin resistance and thyroid nodules. In 2008, Rezzonico
et al. reported that thyroid volumes, measured by ultrasono-
graphy, were higher in patient with insulin resistance than
patients without insulin resistance [10]. The same group
reported that insulin resistance would be an important risk
factor for developing diﬀerentiated thyroid carcinoma [11].
Rezzonicoetal.reportedthatmetformintreatmentdecreases
thyroid nodule volume in patients with small thyroid nodule
and insulin resistance [12].
Ayturk et al. reported that patients with metabolic syn-
drome have higher thyroid nodule prevalence and nodule
volume and demonstrated that insulin resistance may be a
major independent risk factor for development of nodule
formation in iodine-deﬁcient area [13]. To the best of our
knowledge, there is no published study investigating coexist-
ence of colonic polyp and thyroid nodule, so this study was
not designed to evaluate common mechanism. Therefore,we
did not evaluate insulin resistance and this is a major limi-
tation of this study.
Although, there was no patient with thyrotoxicosis, an-
other unexpected result of the study is lower TSH levels in
patients with colonic polyp. This situation can be speculated
as patients with colonic polyp have higher thyroid nodules
prevalence and iodine prophylaxis may results autonomy in
some nodules. No measurement of urinary iodine levels is
another limitation of this study.
Another result of this study is that, patients with ade-
nomatous polyps had 5 or more thyroid nodules compared
to patients with hyperplastic polyps. This coexistence could
not be explained easily. It can be speculated that APC
gene mutation or others play a role in the development of
adenomatous polyp and thyroid nodules [14].
Asexpected,thyroidnodulesweremoreprevalentamong
patients aged 50 years or older, but, the prevalence of colonic
polyp was not diﬀerent between age groups. This could be
explained by relatively narrow range of the age distribution
(53.3 ±11.4y e a r s ) .
5. Conclusion
Thyroid nodules were detected more common in patients
with colonic polyps. Further studies are needed to clarify this
coexistence.
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